Shares of Solventum Corp. SOLV rose 1.14% to $73.86 Thursday, on what proved to be an all-around favorable trading session for the stock market, with the S&P 500 Index SPX rising 0.54% to 6,297.36 and ...

Solventum (NYSE: SOLV) today hosts its 2025 Investor Day and will outline strategic priorities for the Company, its business segments, and its long-range plan (LRP) to drive growth and value creation.

Solventum Launches Preassembled, See-through VH2O2 Test Pack for Low-temp Medical Instrument Sterilization By Solventum Jun 9, 2025 Updated 9 hrs ago 1 of 2 ...

Solventum (NYSE: SOLV) will release its third quarter 2024 financial results on Thursday, November 7, 2024 after the U.S. financial markets close. The company will also host a conference call that ...

With a market cap of $11.5 billion, Solventum Corporation (SOLV) is a U.S.-based healthcare company that was spun off from 3M on April 1, 2024. Headquartered in Maplewood, Minnesota, Solventum ...

Revenue cycle management company Ensemble has entered a collaboration with Solventum to introduce an autonomous coding solution designed to serve all medical specialities, encompassing inpatient ...

Solventum Corp. closed 14.11% below its 52-week high of $85.92, which the company reached on February 26th.

Thermo Fisher Scientific TMO -1.48% said Tuesday it is buying Solventum’s SOLV -1.19% purification and filtration business, confirming an earlier report by The Wall Street Journal. The details ...

Minnesota health products company Solventum is raising its sales guidance due to strong first quarter financial results as it prepares to take on tariffs that executives estimate will cost $80 ...

ST. PAUL, Minn., April 17, 2025 /PRNewswire/ -- Solventum (NYSE: SOLV) will release its first quarter fiscal 2025 financial results on Thursday, May 8, 2025, after the U.S. financial markets ...

Solventum (NYSE: SOLV) will host an investor day on Thursday, March 20, 2025, beginning at approximately 1:00 p.m. Eastern Standard Time. The event will be held in New York City and simultaneously ...

3M spin-off Solventum raised its annual profit forecast on Thursday, betting on strong sales of its wound care and surgical sterilization products.